Key result
Preoperative Sildenafil failed to reduce myocardial injury in children undergoing VSD closure; high-dose Sildenafil increased median CK-MB release.
Why the study?
Sildenafil has strong cardiac preconditioning properties in animal studies and a safe side-effect profile in children, but its effect on reducing myocardial ischaemia/reperfusion injury in children undergoing VSD closure was unknown.
Does preoperative sildenafil preconditioning reduce myocardial injury in children undergoing surgical VSD closure?
RCT (n=39)
double-blind
randomized into three groups
Does preoperative sildenafil preconditioning reduce myocardial injury in children undergoing surgical VSD closure?
Answers are grounded in this paper and cite their sources.
Preoperative sildenafil preconditioning failed to reduce myocardial injury and may increase cardiac enzyme release in children undergoing surgical VSD closure.
OBJECTIVES: Sildenafil has strong cardiac preconditioning properties in animal studies and has a safe side-effect profile in children. Therefore, we evaluated the application of Sildenafil preconditioning to reduce myocardial ischaemia/reperfusion injury in children undergoing surgical ventricular septal defect (VSD) closure. METHODS: This is a randomized, double-blind study. Children (1-17 years) undergoing VSD closure were randomized into three groups: placebo (Control group), preconditioning with 0.06 mg/kg (Sild-L group) and 0.6 mg/kg Sildenafil (Sild-H group). PRIMARY ENDPOINT: troponin release. CK-MB, Troponin I, inflammatory response (IL-6 and TNF-α), bypass and ventilation weaning times, inotropy score and echocardiographic function were assessed. Data expressed as median (range), and a value of P < 0.05 was considered significant. RESULTS: Thirty-nine patients were studied (13/group). Aortic cross-clamp time was similar [27 (18-85) and 27 (12-39) min] in the Control and Sild-L groups, respectively, but significantly longer [39 (20-96) min] in the Sild-H group when compared with the Control group. Area under the curve of CK-MB release was 1105 (620-1855) h ng/ml in the Control group, 1672 (564-2767) h ng/ml in the Sild-L group and was significantly higher in the Sild-H group [1695 (1252-3377) h ng/ml] when compared with the Control group. There were no significant differences in inflammatory response markers, cardiopulmonary bypass and ventilation weaning times, inotropy scores and echocardiographic function between the groups. CONCLUSIONS: In this small study, Sildenafil failed to reduce myocardial injury in children undergoing cardiac surgery, nor does it alter cardiac function, inotropic needs or postoperative course. A subclinical increase in cardiac enzyme release after Sildenafil preconditioning cannot be excluded. CLINICAL TRIALS REGISTRY: CTRI/2014/03/004468.
No takes yet. Share an insight, caveat, or question.
Walavalkar et al. (2015) conducted an RCT in ventricular septal defect (VSD) (n=39). Sildenafil vs. placebo was evaluated on troponin release. Preoperative Sildenafil failed to reduce myocardial injury in children undergoing VSD closure; high-dose Sildenafil increased median CK-MB release.
Synapse has enriched 10 related papers. Consider them for comparative context: